Wednesday, June 17, 2026

Dr. Shuwen Han: Advancing Intestinal Microecology and Colorectal Cancer Research | Best Researcher Award


 Dr. Shuwen Han, an award recipient at the International Research Awards on Infectious Diseases, has made significant contributions to microbial pathogenesis, virulence research, oncology, colorectal cancer, and intestinal microecology. His innovative work explores the relationship between gut microbiota and colorectal cancer, helping improve prevention, diagnosis, and treatment strategies. With over 80 SCI publications, multiple research projects, and international collaborations, Dr. Han continues to drive scientific advancements that impact global healthcare and infectious disease research.

Dr Shuwen Han, Intestinal Microecology, Colorectal Cancer Research, Microbial Pathogenesis, Virulence Research, Oncology Research, Gut Microbiota, Infectious Diseases, Research Excellence, Best Researcher Award,

International Research Awards on
Infectious Diseases
Visit our page : https://infectious-diseases-conferences.pencis.com/
Nominations page : https://w-i.me/smif

#ResearchAwards #ScienceAwards
#worldresearchawards #AcademicAwards #GlobalResearchAwards

Tuesday, June 16, 2026

Dr. Salvatore Giovanni De Simone Receives Excellence in Research Award | Infectious Diseases & Vaccinology Leader


 The International Research Awards on Infectious Diseases proudly honors Dr. Salvatore Giovanni De Simone (Brazil) with the prestigious Excellence in Research Award for his outstanding contributions to Infectious Diseases, Vaccinology, Immunology, Epitope Mapping, and Public Health Research.

Dr. De Simone's pioneering work in vaccine science and pertussis immunology has significantly advanced our understanding of immune responses and vaccine-induced protection. His featured research on screening epitopes through comparative analysis of immune responses in children and mice contributes to the development of next-generation vaccination strategies against pertussis and other infectious diseases.

This recognition celebrates his scientific excellence, global impact, innovation, and dedication to improving public health through cutting-edge infectious disease research.

International Research Awards on
Infectious Diseases
Visit our page :  https://infectious-diseases-conferences.pencis.com/
Nominations page :  https://w-i.me/smif

#InfectiousDiseases #Vaccinology #Immunology #PertussisResearch #VaccineDevelopment #ResearchExcellence

Thursday, June 11, 2026

Prof. Zhijun Song | Ningxia Medical University | China

 

Infectious disease research is well-funded ecosystem focused on pandemic preparedness, antiviral/vaccine development, and combating endemic threats like dengue and antimicrobial resistance (AMR). Key institutions include the National Centre for Infectious Diseases (NCID), and the Communicable Diseases Agency (CDA), which coordinate clinical studies, molecular research, and surveillance. πŸ“Œ Visit: https://infectious-diseases-conferences.pencis.com πŸ“Œ Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee πŸ“Œ Register: https://infectious-diseases-conferences.pencis.com/award-registration/ πŸ“© Contact: infectioussupport@pencis.com Follow Us On: Instagram: https://www.instagram.com/infectious_... Twitter (X): https://x.com/skyla00827177 Blogger: https://infectious2021.blogspot.com/ LinkedIn: https://www.linkedin.com/in/infectiou... facebook : https://www.facebook.com/profile.php?... Tumblr : https://www.tumblr.com/infectiousconferences Pinterest : https://in.pinterest.com/infectiousconferences/

36th Edition of Infectious Summit | 28–29 June 2026 | Bangkok,Thailand

 

Infectious disease research in Bangkok,Thailand is a robust, well-funded ecosystem focused on pandemic preparedness, antiviral/vaccine development, and combating endemic threats like dengue and antimicrobial resistance (AMR). Key institutions include the National Centre for Infectious Diseases (NCID), and the Communicable Diseases Agency (CDA), which coordinate clinical studies, molecular research, and surveillance. πŸ“Œ Visit: https://infectious-diseases-conferences.pencis.com πŸ“Œ Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee πŸ“Œ Register: https://infectious-diseases-conferences.pencis.com/award-registration/ πŸ“© Contact: infectioussupport@pencis.com Follow Us On: Instagram: https://www.instagram.com/infectious_... Twitter (X): https://x.com/skyla00827177 Blogger: https://infectious2021.blogspot.com/ LinkedIn: https://www.linkedin.com/in/infectiou... facebook : https://www.facebook.com/profile.php?... Tumblr : https://www.tumblr.com/infectiousconferences Pinterest : https://in.pinterest.com/infectiousconferences/

Thursday, April 9, 2026

πŸ¦‡ Oita Virus Rediscovery: A Silent Viral Comeback After 50 Years


 

πŸ”¬ 1. Historical Background

The Oita virus (OITV), a member of the Ledantevirus genus within the Rhabdoviridae family, was first isolated in 1972 from the blood of the Japanese horseshoe bat (Rhinolophus cornutus) in Oita Prefecture, Japan . For decades, this virus remained undetected, creating a scientific mystery around its ecological persistence and evolutionary trajectory.


🧬 2. Rediscovery After Half a Century

After nearly 50 years of silence, researchers successfully isolated new strains (OITV 321/2022 and 326/2022) from bat oral swabs in southern Japan. Remarkably, these strains showed over 98% genetic similarity with the original 1972 isolate, indicating extraordinary genetic conservation over time . This discovery highlights the long-term stability of certain bat-associated viruses.


🧫 3. Genetic Stability & Evolutionary Insights

  • High nucleotide identity (>98%) suggests minimal mutation across decades
  • Phylogenetic analysis confirms classification within Ledantevirus subgroup C
  • Indicates slow evolutionary drift, possibly due to stable host-virus interactions

This genetic conservation provides a rare window into viral evolution, suggesting that some bat viruses maintain equilibrium without significant genomic changes.


🦠 4. Host Range & Cellular Infection

Laboratory studies revealed that OITV can infect:

  • 🧍 Human-derived cells
  • 🐭 Rodent and primate cells
  • πŸ¦‡ Bat cell lines

However, it showed no replication in insect cells, indicating a mammalian host preference . This broad host tropism raises concerns about potential cross-species transmission.


🌬️ 5. Transmission Dynamics

Unlike the original blood-derived isolate, the new strains were recovered from oral swabs, suggesting:

  • Possible respiratory transmission pathways
  • Circulation among bats via aerosols or saliva exchange

This shift in detection method signals evolving viral ecology and transmission strategies.


πŸ§ͺ 6. Pathogenicity & Experimental Findings

Animal model experiments showed:

  • No obvious clinical symptoms in infected mice
  • Evidence of viral replication in brain and lungs
  • Transient pulmonary infection via intranasal exposure

These findings suggest a low-pathogenic but systemically capable virus, potentially underdiagnosed in natural settings.


🌍 7. Zoonotic Significance & Public Health

Bats are well-known reservoirs of emerging viruses, often carrying pathogens without symptoms . The ability of OITV to replicate in human cells emphasizes its potential zoonotic risk, although no human infections have yet been confirmed.


🚨 8. Future Perspectives & Surveillance

  • The necessity of continuous viral surveillance in bat populations
  • The necessity of studying the spillover potential into humans
  • The importance of genomic monitoring for emerging variants

✨ Conclusion

The rediscovery of Oita virus after 50 years unveils a fascinating story of viral persistence, genetic stability, and hidden ecological circulation. It underscores the critical importance of wildlife virology in predicting and preventing future infectious disease threats 🧬🌏.

πŸ¦‡ After five decades, the elusive Oita virus resurfaces from bat reservoirs in southern Japan, revealing striking genetic conservation. 🧬 This rediscovery illuminates viral persistence, zoonotic potential, and evolutionary stability, sparking renewed surveillance and research urgency. πŸ”¬ Scientists decode its secrets to better anticipate emerging infectious threats and strengthen global preparedness and resilience. πŸ“Œ Visit: https://infectious-diseases-conferences.pencis.com πŸ“Œ Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee πŸ“Œ Register: https://infectious-diseases-conferences.pencis.com/award-registration/ πŸ“© Contact: infectioussupport@pencis.com Follow Us On: Instagram: https://www.instagram.com/infectious_... Twitter (X): https://x.com/skyla00827177 Blogger: https://infectious2021.blogspot.com/ LinkedIn: https://www.linkedin.com/in/infectiou... facebook : https://www.facebook.com/profile.php?... Tumblr : https://www.tumblr.com/infectiousconferences Pinterest : https://in.pinterest.com/infectiousconferences/

Wednesday, April 8, 2026

🧬 Comprehensive E2 Gene-Based Phylogeny of Classical Swine Fever Virus (CSFV)

 

The study of E2 gene-based phylogeny provides a powerful lens to understand the evolutionary dynamics of Classical Swine Fever Virus (CSFV) πŸ–πŸ¦ . The E2 glycoprotein, a major structural and immunogenic component, plays a crucial role in viral entry and host immune response. By analyzing variations in the E2 gene, researchers can trace viral lineage diversification, identify emerging strains, and refine the global genotype classification system πŸŒπŸ”¬. This approach enhances our understanding of viral transmission patterns and supports effective disease control strategies.


πŸ” 1. Importance of the E2 Gene in CSFV Evolution

The E2 gene is highly variable and serves as a molecular marker for phylogenetic analysis πŸ§ͺ. Its genetic diversity reflects evolutionary pressure, immune escape mechanisms, and host adaptation. Studying E2 sequences enables scientists to distinguish between closely related strains and monitor viral evolution in real-time ⏳.


🌐 2. Emerging Lineages and Genetic Diversity

Recent phylogenetic studies have uncovered new and previously unrecognized CSFV lineages 🚨. These emerging variants highlight the continuous evolution of the virus due to mutation, recombination, and geographical spread. Understanding these lineages is essential for predicting outbreaks and improving surveillance systems πŸ“Š.


🧭 3. Refining the Global Genotype Framework

Traditional CSFV classification divided strains into a limited number of genotypes. However, E2 gene-based phylogeny has enabled a more refined and detailed genotype framework πŸ“š. This updated classification improves accuracy in identifying virus origins, tracking cross-border transmission, and designing targeted interventions 🌎.


πŸ›‘️ 4. Implications for Vaccine Development and Control

The identification of diverse E2 variants directly impacts vaccine efficacy πŸ’‰. Vaccines developed against older genotypes may show reduced protection against emerging strains. Therefore, continuous phylogenetic monitoring supports the development of updated vaccines and helps implement region-specific control measures 🚧.


πŸ“ˆ 5. Applications in Epidemiology and Disease Surveillance

E2-based phylogenetic analysis is widely used in molecular epidemiology πŸ”Ž. It assists in outbreak investigations, tracing infection sources, and understanding transmission networks. This information is vital for policymakers and veterinary health authorities to design effective prevention strategies πŸ₯.


Conclusion
Comprehensive E2 gene-based phylogeny is a cornerstone in modern CSFV research, revealing hidden evolutionary patterns and strengthening global genotype frameworks. It not only deepens scientific understanding but also plays a pivotal role in disease control, vaccine innovation, and global food security 🌾🐷.

πŸ“Œ Visit: https://infectious-diseases-conferences.pencis.com πŸ“Œ Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee πŸ“Œ Register: https://infectious-diseases-conferences.pencis.com/award-registration/ πŸ“© Contact: infectioussupport@pencis.com Follow Us On: Instagram: https://www.instagram.com/infectious_... Twitter (X): https://x.com/skyla00827177 Blogger: https://infectious2021.blogspot.com/ LinkedIn: https://www.linkedin.com/in/infectiou... facebook : https://www.facebook.com/profile.php?... Tumblr : https://www.tumblr.com/infectiousconferences Pinterest : https://in.pinterest.com/infectiousconferences/

Tuesday, February 10, 2026

Biogenic Copper-Based Nanoparticles: Emerging Antimicrobial Agents Against Pathogenic Microorganisms | Nanomedicine & Infection Control #researchawards

Introduction

Biogenic copper-based nanoparticles (CuNPs) have emerged as promising antimicrobial agents due to their potent activity and environmentally sustainable synthesis routes. Green synthesis approaches utilize plants, microorganisms, and biological wastes, where phytochemicals, enzymes, and proteins act as natural reducing and stabilizing agents. These processes avoid toxic chemicals, operate under mild conditions, and yield nanoparticles typically smaller than 100 nm with bioactive surface coatings. Such features not only enhance antimicrobial performance but also align with global demands for eco-friendly nanotechnologies in healthcare, agriculture, aquaculture, and food safety.

Green Synthesis Strategies and Biological Control of Nanoparticle Properties

Biological systems play a decisive role in governing the morphology, size, crystallinity, and stability of copper-based nanoparticles. Plant extracts rich in polyphenols, flavonoids, and terpenoids enable rapid reduction and effective capping, while bacteria, fungi, and algae provide enzymatic and protein-mediated pathways for controlled nanoparticle formation. The choice of biological source, extraction method, and reaction parameters strongly influences nanoparticle uniformity, dispersibility, and long-term stability, directly impacting antimicrobial efficiency.

Antimicrobial Mechanisms of Biogenic Copper-Based Nanoparticles

The antimicrobial activity of biogenic CuNPs arises from multiple interconnected mechanisms. These include the generation of reactive oxygen species (ROS), sustained release of Cu²⁺ ions, disruption of microbial cell membranes, and interference with enzymatic, metabolic, and genetic processes. Surface-bound biomolecules from green synthesis further enhance microbial interaction and biofilm penetration, enabling broad-spectrum activity against Gram-positive and Gram-negative bacteria, fungi, and resistant microbial communities.

Monometallic versus Hybrid Copper-Based Nanoparticle Systems

While monometallic Cu and CuO nanoparticles exhibit strong antimicrobial properties, hybrid systems such as Ag–Cu, Zn–CuO, and CuS nanoparticles demonstrate enhanced efficacy through synergistic effects. These hybrids integrate redox activity, ion release, and in some cases photothermal or photocatalytic mechanisms, leading to improved microbial killing at lower doses. Comparative studies highlight the potential of hybrid systems to overcome antimicrobial resistance and expand functional applications.

Applications in Medicine, Agriculture, Aquaculture, and Food Safety

Biogenic copper-based nanoparticles have found diverse applications due to their antimicrobial versatility. In medicine, they are incorporated into wound dressings, implants, and antimicrobial coatings. In agriculture and aquaculture, they support sustainable crop protection and disease management by reducing reliance on chemical pesticides and antibiotics. In food safety and packaging, CuNPs help inhibit spoilage and pathogenic microorganisms, extending shelf life while maintaining eco-friendly standards.

Toxicity, Challenges, and Future Directions

Despite their benefits, the toxicity of biogenic CuNPs is highly context-dependent, influenced by size, shape, surface chemistry, capping agents, concentration, and exposure conditions. Poorly capped or ultra-small nanoparticles may induce cytotoxicity, hemolysis, developmental defects, or growth inhibition, whereas appropriate functionalization improves biocompatibility and selectivity. Future research must focus on standardized physicochemical characterization, harmonized toxicity testing, and mechanistic studies to enable safe translation, regulatory approval, and responsible commercialization of biogenic copper-based nanomaterials.

πŸ”— Visit: https://infectious-diseases-conferences.pencis.com
🌟 Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/ ecategory=Awards&rcategory=Awardee
πŸ“ Registration page: https://infectious-diseases-conferences.pencis.com/award-registration/
πŸ“§ Contact us: infectioussupport@pencis.com

Hashtags:

#CopperNanoparticles, #GreenNanotechnology, #BiogenicNanoparticles, #AntimicrobialNanomaterials, #SustainableSynthesis, #NanoMedicine, #AgriculturalNanotech, #AquacultureHealth, #FoodSafetyNanotech, #HybridNanoparticles, #CuONanoparticles, #ROSMechanism, #BiofilmControl, #EcoFriendlyMaterials, #Nanotoxicology, #RegulatoryNanotech, #PlantMediatedSynthesis, #MicrobialNanoparticles, #NanoparticleCharacterization, #FutureNanotechnology,

Dr. Shuwen Han: Advancing Intestinal Microecology and Colorectal Cancer Research | Best Researcher Award

 Dr. Shuwen Han, an award recipient at the International Research Awards on Infectious Diseases, has made significant contributions to micro...